Surgical resection followed by radioactive iodine (131I) therapy constitutes a standard
treatment for differentiated thyroid cancer. 131I is normally excreted through the kidneys …

We describe detailed administration of thyroidal and extrathyroidal doses of radioiodine to a
patient with end-stage renal disease on hemodialysis. A thorough description of area under …

Treatment with radioactive iodine (131I) may be necessary for thyroid cancer or for
hyperthyroidism in patients with end-stage renal disease who require hemodialysis …

Ablative radioiodine therapy is the main standard treatment for patients with differentiated
thyroid cancer after total thyroidectomy. After radioiodine therapy, more than 70% of the …

AbstrAct bAcKGrOUND: Iodine 131 ablation following total thyroidectomy is considered an
indispensable element of successful treatment of differentiated thyroid carcinoma (Dtc) …

The aim of this study was to analyze the disposition of radioiodine used for the ablation of
thyroid remnants after radical surgery for a differentiated thyroid carcinoma in a patient on …

Purpose Radioiodine (RAI) is a cornerstone in the treatment of Differentiated Thyroid Cancer
(DTC). In patients on haemodialysis due to End-Stage Renal Disease (ESRD), it must be …

Radioactive iodine (131I) therapy may be used to treat thyroid cancer in end-stage renal
disease patients who undergo hemodialysis. Because iodine uses predominantly renal …

Thyroid malignancy is common among patients with renal impairment compared with the
general population. Treatment involves surgical resection and radioactive iodine therapy …

Objectives Radioiodine therapy could be challenging in chronic renal failure patients
requiring hemodialysis. The aim of this study was to establish the effects of hemodialysis on …